readthroughSign in
CompanyBHVNNYSENew Haven, CT

Biohaven Ltd.

Biohaven develops opakalim, a Kv7.2/7.3 potassium channel activator for epilepsy treatment.

SCHEDULE 13G/ANov 16Latest SEC filing
Oct 29Latest story